We tend to think of antibiotic resistance as a hospital problem. A patient gets an infection. The doctor prescribes an antibiotic. The bacteria survive. Resistance spreads.
That story is true — but it is radically incomplete.
The largest breeding ground for antibiotic resistance is not the ICU. It is the environment: rivers choked with pharmaceutical waste, oceans threaded with microplastics, soils warming under a changing climate, and fish farms dosing entire ecosystems with antibiotics. These are the hidden reservoirs where resistance genes multiply, recombine, and eventually find their way into the bacteria that infect us.
This is the One Health dimension of AMR — the recognition that human, animal, and environmental health are not separate domains but a single, interconnected system. And right now, we are contaminating every part of it.
The Rivers Run with Antibiotics
In 2025, researchers at McGill University published a landmark study in PNAS Nexus that mapped antibiotic contamination in global river systems. The numbers were staggering: of the 30,300 tonnes of the 40 most-used antibiotics consumed by humans annually, 9,500 tonnes (31%) are released into rivers, and 3,250 tonnes reach the world's oceans.
And that figure only accounts for human consumption. It does not include antibiotics from livestock farming, aquaculture, or pharmaceutical manufacturing — which are often far larger sources.
At concentrations far below therapeutic levels, these antibiotics still exert selective pressure on environmental bacteria. They do not kill — they train. Subtherapeutic concentrations are, in some ways, worse than full doses: they create the exact conditions under which bacteria can gradually evolve resistance without being eliminated.
CASE STUDY: HYDERABAD, INDIA
Hyderabad is the "Pharmacy of the World" — home to some of India's largest bulk drug manufacturers. In the Patancheru-Bollaram industrial estate, effluent from 90 pharmaceutical companies flows into common treatment plants and then into the Musi River.
Measured concentrations: ciprofloxacin at 14,000 µg/L — roughly 1,000 times the safe limit, and enough to treat 44,000 patients. Enrofloxacin at 210 µg/L. Multiple other antibiotics at dangerous levels.
The result: more than 95% of bacterial samples from these waters carry carbapenemase genes — the resistance mechanisms that defeat our last-resort antibiotics. All 90 bacterial strains isolated from the Musi River were multi-drug resistant. Some were extensively drug-resistant.
These are not contained. A 2010 Swedish study found that 7 of 8 travellers to India returned carrying drug-resistant bacteria. Resistance born in Hyderabad's rivers reaches Stockholm's hospitals.
The Plastisphere: When Two Crises Merge
Microplastics are everywhere — in our oceans, soils, drinking water, blood. But their role in antibiotic resistance is only now coming into focus, and the findings are alarming.
Microplastic surfaces in water and soil become colonized by bacterial communities, forming what scientists call the "plastisphere" — biofilm ecosystems growing on plastic particles. These plastisphere communities are not random assemblages. They are enriched in antibiotic-resistant bacteria, mobile genetic elements (integrons, transposons, plasmids), and the machinery for horizontal gene transfer.
In other words: microplastics are platforms for resistance gene exchange.
The Mechanisms
A December 2025 study in Nature Communications showed precisely how this works. Polystyrene nano- and microplastics of different sizes (20 nm, 120 nm, 1 µm) were tested for their effect on conjugative transfer of antibiotic resistance genes between bacteria:
- Nanoplastics (20 nm and 120 nm) broadly facilitated conjugation — the direct cell-to-cell transfer of resistance plasmids — in both Gram-negative (E. coli) and Gram-positive (E. faecalis) donors
- Even at environmentally relevant concentrations (0.1 mg/L), microplastics enhanced resistance gene transfer
- The mechanism involves increased reactive oxygen species (ROS), elevated ATP levels, and greater cell membrane permeability — all of which promote the conjugation machinery
A March 2026 paper in Bioresource Technology added another dimension: microplastics promote conjugative transfer through specific membrane protein interactions, with oxidative stress and increased cellular energy supply driving the process.
Microplastics × AMR: The Numbers
The soil story is equally concerning. A November 2024 Nature Communications study found that as microplastic diversity increases (different polymers, shapes, and colors), antibiotic resistance gene abundance rises in lockstep, along with virulence factor genes and mobile genetic elements.
Two planetary-scale pollution crises — plastic and antibiotics — are not merely co-occurring. They are synergizing. Microplastics carry resistant bacteria to new environments via water currents and wind. They concentrate bacteria on their surfaces, creating hotspots for gene exchange. And they chemically stress bacterial cells in ways that activate the very mechanisms bacteria use to share resistance genes.
A Warming World Breeds Resistance
Climate change is not just an ecological crisis. It is an antimicrobial resistance accelerant.
The evidence has been building for years, but 2025 and 2026 brought definitive studies:
Temperature Drives Resistance
A June 2025 study in Nature Ecology & Evolution combined field experiments, global metagenomic data, and microbial culturing to show that warming enriches bacteria carrying antibiotic resistance genes and virulence factor genes in soils worldwide. The effect is most pronounced in colder regions — precisely where climate change is advancing fastest.
The mechanism: higher temperatures increase bacterial metabolic complexity and adaptability, accelerating genetic alterations that promote resistance gene development. Machine learning models predicted that continued warming will increase soil ARG abundance globally, with fossil-fuel-dependent regions hit hardest.
A 2026 review in Environmental Reviews quantified the relationship: a 10°C increase in ambient temperature correlates with a 4–17% rise in bacterial resistance. The drivers include enhanced horizontal gene transfer, stress-induced mutagenesis, and upregulated efflux pump expression.
The Scale
A landmark April 2025 study in Nature Medicine analyzed 4,502 AMR surveillance records covering 32 million tested isolates from 101 countries (1999–2022). The findings:
- AMR disparities between high-income and low/middle-income countries are growing
- Climate and socioeconomic factors are significant predictors of resistance rates
- Under sustainable development scenarios, AMR prevalence could be reduced by 5.1% by 2050
- Without action, warming and inequality will drive resistance rates higher, particularly in regions least equipped to respond
THE PERMAFROST PARADOX
In February 2026, Romanian researchers revived a Psychrobacter bacterium from a 5,000-year-old ice cave. Despite predating the antibiotic era by millennia, it carried more than 100 resistance-related genes and was resistant to 10 modern antibiotics across 8 classes.
From Siberian permafrost, bacteria dating back two million years have been found resistant to at least 10 modern antibiotics.
This tells us something profound: antibiotic resistance is not solely a human-created problem. It is an ancient evolutionary strategy — bacteria have been waging chemical warfare against each other for billions of years. But it also raises a chilling possibility: as permafrost thaws under climate change, it may release bacteria carrying resistance genes we have never encountered — pre-existing countermeasures to drugs we have not yet invented.
The Aquaculture Blind Spot
Aquaculture now supplies more than half the world's seafood. It is also one of the most underappreciated drivers of antibiotic resistance.
Intensive fish and shrimp farming uses antibiotics both therapeutically and — in many countries until recently — as growth promoters. These antibiotics are released directly into aquatic environments, creating the same selective pressure as pharmaceutical pollution in rivers, but on a massive scale across coastal ecosystems.
Colistin: The Last Resort Lost to Fish Farms
Perhaps the most alarming example involves colistin, one of our last-resort antibiotics for multidrug-resistant Gram-negative infections. Research has traced the emergence of mcr-1 — the plasmid-borne gene for transferable colistin resistance — to aquaculture environments.
A study of 27 aquaculture zones spanning 5,000 km of southern China's coastline found mcr-1 and 13 other resistance genes in all water samples. Most critically, colistin resistance was transmissible between bacterial communities — it could move from aquaculture bacteria to human pathogens.
China banned colistin as an animal growth promoter in 2017. India followed in 2019. But the damage was done: colistin-resistant bacteria had already entered human populations. Cases of animal-transferred colistin-resistant infections continue to be recorded.
In late 2025, aquaculture was formally recognized at the EU One Health Conference as a "missing piece" in AMR action plans. It is being integrated — but slowly, and against an industry that feeds billions.
The Wastewater Gap
Wastewater treatment plants (WWTPs) are our primary barrier between antibiotic-contaminated sewage and the environment. But they were never designed to remove resistance genes.
A 2025 study in npj Clean Water found that conventional treatment achieves 63–94% removal of antibiotic resistance genes — which sounds reasonable until you consider the volume flowing through. A large WWTP processing hundreds of millions of liters daily, removing 90% of ARGs, still releases enormous absolute quantities of resistance genes into rivers and oceans.
Key findings from recent research:
- Certain resistance gene subtypes (sul2, tetG) persist through treatment and are detectable in effluent
- ARG abundance in influent is seasonal — higher in winter when antibiotic prescriptions peak
- Advanced treatments (ozonation, UV, granular activated carbon) significantly improve removal, but are expensive and rarely deployed in low-income settings
- Nature-based solutions like constructed wetlands show promise — achieving 3.7–4.1 log reduction in resistant E. coli versus 2.5–2.8 log for conventional activated sludge
In high-income countries, hospital and industrial wastewater is typically co-treated with municipal sewage — diluting but not eliminating resistance. In low-income countries, hospital wastewater often flows directly into rivers and lakes untreated.
The Convergence
These are not five separate problems. They are one system.
Pharmaceutical waste enters rivers. Microplastics in those rivers provide surfaces for resistant bacteria to congregate and exchange genes. Climate warming accelerates the rate of gene transfer and expands the geographic range of resistant organisms. Aquaculture pumps antibiotics directly into aquatic ecosystems. And wastewater treatment — our one engineered barrier — lets a significant fraction through.
Each driver makes the others worse:
- Warming increases bacterial metabolic activity, which increases the rate of conjugation on microplastic surfaces
- Pharmaceutical pollution selects for resistant strains, which then colonize the plastisphere preferentially
- Aquaculture runoff feeds into the same waterways receiving pharmaceutical and microplastic contamination
- Thawing permafrost introduces ancient resistance genes into environments already primed for gene exchange
What Can Be Done
The One Health framework — integrating human, animal, and environmental health strategies — is the right paradigm. But implementation is lagging.
What is working:
- China's 2017 ban on colistin as a growth promoter has reduced (though not eliminated) mcr-1 prevalence in livestock
- India's National Action Plan on AMR 2.0 (2025–29) now includes environmental surveillance
- The EU's 2025 One Health Conference formally integrated aquaculture into AMR frameworks
- Nature-based wastewater solutions (constructed wetlands) are proving more effective than conventional treatment for ARG removal
- Rwanda's ePOCT+ digital diagnostic tool cut antibiotic prescriptions from 71% to 25% — less consumption means less environmental release
What is needed:
- Environmental AMR surveillance at scale. GLASS tracks clinical resistance. We need equivalent systems for rivers, soils, and marine environments
- Pharmaceutical manufacturing standards. The Hyderabad model — where production zones become resistance factories — is unacceptable. Zero Liquid Discharge must be mandatory, not aspirational
- Microplastic regulation. The plastics treaty under negotiation must consider the AMR dimension
- Upgraded wastewater treatment. Tertiary treatment (ozonation, UV, activated carbon) should be standard in regions with high antibiotic consumption
- Climate-AMR integration. Climate adaptation plans must account for rising resistance rates as temperatures increase
The Bottom Line
Antibiotic resistance is not a problem that can be solved inside hospitals. The environment is both the origin and the amplifier of resistance. Rivers, oceans, soils, and the atmosphere are not passive recipients of our antibiotic waste — they are active participants in the evolution of resistance.
Every tonne of antibiotics flushed into a river. Every microplastic fragment colonized by resistant bacteria. Every fraction of a degree of warming. These are not abstract environmental concerns. They are direct contributors to the treatment failures that kill 1.27 million people every year.
We cannot fight antibiotic resistance without fighting the environmental crises that fuel it. They are the same fight.
Sources: McGill University / PNAS Nexus (2025) — global river antibiotic contamination; Nature Communications (Dec 2025) — micro/nanoplastics and conjugative ARG transfer; Nature Communications (Nov 2024) — microplastic diversity and soil ARGs; Nature Ecology & Evolution (Jun 2025) — climate warming and soil resistance; Nature Medicine (Apr 2025) — global AMR forecasting under climate scenarios; Nature Reviews Microbiology (2026) — climate change and AMR review; npj Clean Water (2025) — WWTP ARG removal efficiency; ScienceDaily / Frontiers in Microbiology (Feb 2026) — 5,000-year-old resistant bacteria; ISME Communications — colistin resistance in coastal aquaculture; One Health Advances (2025) — global ARG distribution in aquaculture; Changing Markets Foundation — Hyderabad pharmaceutical pollution report.